Literature DB >> 23142830

Vestibular migraine: diagnostic criteria.

Thomas Lempert1, Jes Olesen, Joseph Furman, John Waterston, Barry Seemungal, John Carey, Alexander Bisdorff, Maurizio Versino, Stefan Evers, David Newman-Toker.   

Abstract

This paper presents diagnostic criteria for vestibular migraine, jointly formulated by the Committee for Classification of Vestibular Disorders of the Bárány Society and the Migraine Classification Subcommittee of the International Headache Society (IHS). The classification includes vestibular migraine and probable vestibular migraine. Vestibular migraine will appear in an appendix of the third edition of the International Classification of Headache Disorders (ICHD) as a first step for new entities, in accordance with the usual IHS procedures. Probable vestibular migraine may be included in a later version of the ICHD, when further evidence has been accumulated. The diagnosis of vestibular migraine is based on recurrent vestibular symptoms, a history of migraine, a temporal association between vestibular symptoms and migraine symptoms and exclusion of other causes of vestibular symptoms. Symptoms that qualify for a diagnosis of vestibular migraine include various types of vertigo as well as head motion-induced dizziness with nausea. Symptoms must be of moderate or severe intensity. Duration of acute episodes is limited to a window of between 5 minutes and 72 hours.

Entities:  

Mesh:

Year:  2012        PMID: 23142830     DOI: 10.3233/VES-2012-0453

Source DB:  PubMed          Journal:  J Vestib Res        ISSN: 0957-4271            Impact factor:   2.435


  209 in total

Review 1.  [Diagnostic criteria for Menière's disease according to the Classification Committee of the Bárány Society].

Authors:  J A Lopez-Escamez; J Carey; W-H Chung; J A Goebel; M Magnusson; M Mandalà; D E Newman-Toker; M Strupp; M Suzuki; F Trabalzini; A Bisdorff
Journal:  HNO       Date:  2017-11       Impact factor: 1.284

2.  Mal de debarquement syndrome: new insights.

Authors:  Yoon-Hee Cha
Journal:  Ann N Y Acad Sci       Date:  2015-02-27       Impact factor: 5.691

3.  Endolymphatic hydrops in patients with vestibular migraine and auditory symptoms.

Authors:  Robert Gürkov; Claudia Kantner; Michael Strupp; W Flatz; Eike Krause; Birgit Ertl-Wagner
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-10       Impact factor: 2.503

4.  Five keys for diagnosing most vertigo, dizziness, and imbalance syndromes: an expert opinion.

Authors:  Thomas Brandt; Michael Strupp; Marianne Dieterich
Journal:  J Neurol       Date:  2013-11-30       Impact factor: 4.849

Review 5.  Epidemiology of Vestibular Impairments in a Pediatric Population.

Authors:  Sylvette R Wiener-Vacher; Juliette Quarez; Audrey Le Priol
Journal:  Semin Hear       Date:  2018-07-20

6.  Association between Syncope and Tumarkin Attacks in Ménière's Disease.

Authors:  Ilmari Pyykkö; Vinaya Manchaiah; Jing Zou; Hilla Levo; Erna Kentala
Journal:  J Int Adv Otol       Date:  2019-04       Impact factor: 1.017

7.  The Dizziness Handicap Inventory does not correlate with vestibular function tests: a prospective study.

Authors:  Chun Wai Yip; Michael Strupp
Journal:  J Neurol       Date:  2018-03-20       Impact factor: 4.849

8.  Abnormal Tilt Perception During Centrifugation in Patients with Vestibular Migraine.

Authors:  Joanne Wang; Richard F Lewis
Journal:  J Assoc Res Otolaryngol       Date:  2016-03-08

9.  Caloric test and video-head-impulse: a study of vertigo/dizziness patients in a community hospital.

Authors:  Andrea Mahringer; Holger A Rambold
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-03-15       Impact factor: 2.503

10.  Endolymphatic space size in patients with vestibular migraine and Ménière's disease.

Authors:  Takafumi Nakada; Tadao Yoshida; Kenji Suga; Masahiro Kato; Hironao Otake; Ken Kato; Masaaki Teranishi; Michihiko Sone; Saiko Sugiura; Kayao Kuno; Ilmari Pyykkö; Shinji Naganawa; Hirohisa Watanabe; Gen Sobue; Tsutomu Nakashima
Journal:  J Neurol       Date:  2014-08-07       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.